Your session is about to expire
← Back to Search
COPD Care Pathway for Chronic Obstructive Pulmonary Disease
N/A
Waitlist Available
Led By Thomas Lycan, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 months
Awards & highlights
Study Summary
This trial will design a care pathway to help COPD patients get evidence-based care, and measure if it reduces hospitalization risk.
Who is the study for?
This trial is for people who may have COPD and are undergoing or have had immunotherapy for any cancer, or healthcare providers working in oncology or with COPD patients. Participants must understand and consent to the study.Check my eligibility
What is being tested?
The study aims to create a care pathway for managing COPD in community oncology clinics. It involves surveys and interviews (Arm A) to develop this pathway, setting up for a future randomized controlled trial.See study design
What are the potential side effects?
Since the intervention includes surveys and interviews rather than medical treatments, there are no direct physical side effects associated with participating in this clinical trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Participants that Agree the COPD Pathway is Feasible - Feasibility Implementation Measure (FIM)
Secondary outcome measures
Number of Barriers Identified to the Implementation of a COPD Intervention for Community Oncology Clinics
Number of Clinics Ready to Adopt the COPD Care Pathway - Organizational Readiness for Implementing Change (ORIC)
Number of Participants to Find the COPD Care Pathway Acceptable - Acceptability Implementation Measure (AIM).
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Arm B - Participants only COPD Care PathwayExperimental Treatment1 Intervention
Investigators will use the COPD care pathway developed by Arm A as the intervention in single-arm pilot study to test its feasibility and other implementation outcomes.
Group II: Aim A - Participants and ProvidersExperimental Treatment1 Intervention
Arm A will use the user-centered design process to survey pulmonology content experts, oncology providers, and patients and interview a smaller subset. Specifically, we will measure the perceived efficacy of various components of COPD management using a survey of patients with thoracic cancer and oncology providers.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,239 Previous Clinical Trials
1,004,183 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,153 Total Patients Enrolled
Thomas Lycan, MDPrincipal InvestigatorWake Forest Baptist Comprehensive Cancer Center
1 Previous Clinical Trials
28 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Aim A - Participants and Providers
- Group 2: Arm B - Participants only COPD Care Pathway
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there potential hazards associated with participating in the Surveys and Interviews - Arm A trial?
"Although there is only limited evidence of efficacy, Surveys and Interviews - Arm A has been rated a 2 for safety due to the existing data supporting its security."
Answered by AI
Are physicians still enrolling patients in this research endeavor?
"According to clinicaltrials.gov, this study is no longer enrolling candidates at this time. It was originally posted on September 1st 2023 and last modified on August 1st 2023; however, there are presently 1063 studies actively seeking participants across the globe."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger